These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
|
incorporation or organization)
|
|
Identification No.)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
|
|
|
|
Nasdaq Global Select Market
|
|
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
|
|
|
|
Page
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||||||
|
Net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Selling, general and administrative
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Goodwill and other impairment charges
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Amortization of intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Income (loss) from operations
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Interest income
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Interest expense
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Other—net
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||
|
Total other expense, net
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Income (loss) before income taxes
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Provision for (benefit from) income taxes
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Basic
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Diluted
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Shares used in computation:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Basic
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Diluted
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||||||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Other comprehensive income (loss):
(1)
|
|
|
|
|
|
|
|
||||||||
|
Translation adjustment, net of taxes
(2)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Defined benefit pension plans, net of taxes
(3)
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
Other comprehensive loss, net of tax
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Comprehensive income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
(1)
|
Reclassification adjustments were not significant during the
three and six months ended
April 4, 2020
and
March 30, 2019
.
|
|
(2)
|
Tax benefits of
$
|
|
(3)
|
Tax expenses of
$
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
Restricted cash
|
|
|
|
|
|
||
|
Short-term investments
|
|
|
|
|
|
||
|
Accounts receivable—net of allowances of $6,597 and $8,690, respectively
|
|
|
|
|
|
||
|
Inventories
|
|
|
|
|
|
||
|
Prepaid expenses and other assets
|
|
|
|
|
|
||
|
Total current assets
|
|
|
|
|
|
||
|
Property and equipment, net
|
|
|
|
|
|
||
|
Goodwill
|
|
|
|
|
|
||
|
Intangible assets, net
|
|
|
|
|
|
||
|
Non-current restricted cash
|
|
|
|
|
|
||
|
Other assets
|
|
|
|
|
|
||
|
Total assets
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Short-term borrowings and current-portion of long-term obligations
|
$
|
|
|
|
$
|
|
|
|
Accounts payable
|
|
|
|
|
|
||
|
Income taxes payable
|
|
|
|
|
|
||
|
Other current liabilities
|
|
|
|
|
|
||
|
Total current liabilities
|
|
|
|
|
|
||
|
Long-term obligations
|
|
|
|
|
|
||
|
Other long-term liabilities
|
|
|
|
|
|
||
|
Commitments and contingencies (Note 13)
|
|
|
|
|
|
||
|
Stockholders' equity:
|
|
|
|
|
|
||
|
Common stock, Authorized—500,000 shares, par value $.01 per share:
|
|
|
|
|
|
||
|
Outstanding— 24,192 shares and 23,982 shares, respectively
|
|
|
|
|
|
||
|
Additional paid-in capital
|
|
|
|
|
|
||
|
Accumulated other comprehensive loss
|
(
|
)
|
|
(
|
)
|
||
|
Retained earnings
|
|
|
|
|
|
||
|
Total stockholders’ equity
|
|
|
|
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
|
|
|
$
|
|
|
|
|
Common
Stock
Shares
|
|
Common
Stock
Par
Value
|
|
Add.
Paid-in
Capital
|
|
Accum.
Other
Comp.
Income (Loss)
|
|
Retained
Earnings
|
|
Total
|
|||||||||||
|
Balances, September 29, 2018
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Common stock issued under stock plans, net of shares withheld for employee taxes
|
|
|
|
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||
|
Repurchases of common stock
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|||||
|
Other comprehensive loss, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
|||||
|
Balances, December 29, 2018
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Common stock issued under stock plans, net of shares withheld for employee taxes
|
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||
|
Repurchases of common stock
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|||||
|
Other comprehensive loss, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
|||||
|
Balances, March 30, 2019
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
|
Common
Stock
Shares
|
|
Common
Stock
Par
Value
|
|
Add.
Paid-in
Capital
|
|
Accum.
Other
Comp.
Income (Loss)
|
|
Retained
Earnings
|
|
Total
|
|||||||||||
|
Balances, September 28, 2019
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Common stock issued under stock plans, net of shares withheld for employee taxes
|
|
|
|
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|||||
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|||||
|
Balances, December 28, 2019
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Common stock issued under stock plans, net of shares withheld for employee taxes
|
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
(
|
)
|
|||||
|
Other comprehensive loss, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
|||||
|
Balances, April 4, 2020
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
|
Six Months Ended
|
|
||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
||||
|
Cash flows from operating activities:
|
|
|
|
|
|
|
||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
|
|
|||
|
Depreciation and amortization
|
|
|
|
|
|
|
||
|
Amortization of intangible assets
|
|
|
|
|
|
|
||
|
Impairment of goodwill
|
|
|
|
|
|
|
||
|
Impairment of long-lived assets
|
|
|
|
|
|
|
||
|
Impairment of investment
|
|
|
|
|
|
|
||
|
Deferred income taxes
|
(
|
)
|
|
(
|
)
|
|
||
|
Amortization of debt issuance cost
|
|
|
|
|
|
|
||
|
Stock-based compensation
|
|
|
|
|
|
|
||
|
Non-cash restructuring charges
|
|
|
|
|
|
|
||
|
Amortization of operating right of use assets
|
|
|
|
|
|
|
||
|
Other non-cash expense (income)
|
|
|
|
(
|
)
|
|
||
|
Changes in assets and liabilities, net of effect of acquisitions:
|
|
|
|
|
|
|
||
|
Accounts receivable
|
|
|
|
|
|
|
||
|
Inventories
|
(
|
)
|
|
(
|
)
|
|
||
|
Prepaid expenses and other assets
|
(
|
)
|
|
|
|
|
||
|
Other long-term assets
|
|
|
|
|
|
|
||
|
Accounts payable
|
|
|
|
(
|
)
|
|
||
|
Income taxes payable/receivable
|
(
|
)
|
|
(
|
)
|
|
||
|
Operating lease liabilities
|
(
|
)
|
|
|
|
|
||
|
Other current liabilities
|
|
|
|
(
|
)
|
|
||
|
Other long-term liabilities
|
(
|
)
|
|
(
|
)
|
|
||
|
Net cash provided by operating activities
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Cash flows from investing activities:
|
|
|
|
|
|
|
||
|
Purchases of property and equipment
|
(
|
)
|
|
(
|
)
|
|
||
|
Proceeds from dispositions of property and equipment
|
|
|
|
|
|
|
||
|
Purchases of available-for-sale securities
|
(
|
)
|
|
(
|
)
|
|
||
|
Proceeds from sales and maturities of available-for-sale securities
|
|
|
|
|
|
|
||
|
Acquisition of businesses, net of cash acquired
|
|
|
|
(
|
)
|
|
||
|
Investment at cost
|
|
|
|
(
|
)
|
|
||
|
Net cash used in investing activities
|
(
|
)
|
|
(
|
)
|
|
||
|
|
|
|
|
|
||||
|
Cash flows from financing activities:
|
|
|
|
|
|
|
||
|
Short-term borrowings
|
|
|
|
|
|
|
||
|
Repayments of short-term borrowings
|
(
|
)
|
|
(
|
)
|
|
||
|
Repayments of long-term borrowings
|
(
|
)
|
|
(
|
)
|
|
||
|
Issuance of common stock under employee stock option and purchase plans
|
|
|
|
|
|
|
||
|
Net settlement of restricted common stock
|
(
|
)
|
|
(
|
)
|
|
||
|
Repurchase of common stock
|
|
|
|
(
|
)
|
|
||
|
Net cash used in financing activities
|
(
|
)
|
|
(
|
)
|
|
||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(
|
)
|
|
(
|
)
|
|
||
|
Net increase in cash, cash equivalents and restricted cash
|
|
|
|
|
|
|
||
|
Cash, cash equivalents and restricted cash, beginning of period
|
|
|
|
|
|
|
||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
||||
|
Non-cash investing and financing activities:
|
|
|
|
|
||||
|
Unpaid property and equipment purchases
|
$
|
|
|
|
$
|
|
|
|
|
|
April 4,
2020 |
|
March 30,
2019 |
||||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
Restricted cash, current
|
|
|
|
|
|
||
|
Restricted cash, non-current
|
|
|
|
|
|
||
|
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statement of cash flows
|
$
|
|
|
|
$
|
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||||
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
||||||||
|
Net sales:
|
|
|
|
|
|
|
|
||||||||
|
Products
(1)
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Other product and service revenues
(2)
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Six Months Ended
|
||||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||||
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
||||||||
|
Net sales:
|
|
|
|
|
|
|
|
||||||||
|
Products
(1)
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Other product and service revenues
(2)
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||||
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
||||||||
|
Net sales:
|
|
|
|
|
|
|
|
||||||||
|
Microelectronics
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Materials processing
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
OEM components and instrumentation
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Scientific and government programs
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Six Months Ended
|
||||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||||
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
||||||||
|
Net sales:
|
|
|
|
|
|
|
|
||||||||
|
Microelectronics
|
$
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Materials processing
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
OEM components and instrumentation
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Scientific and government programs
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Beginning balance, September 28, 2019
(1)
|
|
$
|
|
|
|
Additions to customer deposits and deferred revenue
|
|
|
|
|
|
Amount of customer deposits and deferred revenue recognized in income
(2)
|
|
(
|
)
|
|
|
Translation adjustments
|
|
(
|
)
|
|
|
Ending balance, April 4, 2020
(3)
|
|
$
|
|
|
|
|
Remainder of fiscal 2020
|
|
Thereafter
|
|
Total
|
||||||
|
Performance obligations as of April 4, 2020
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Tangible assets:
|
|
||
|
Cash
|
$
|
|
|
|
Accounts receivable
|
|
|
|
|
Inventories
|
|
|
|
|
Prepaid expenses and other assets
|
|
|
|
|
Deferred tax assets
|
|
|
|
|
Property and equipment
|
|
|
|
|
Liabilities assumed
|
(
|
)
|
|
|
Intangible assets:
|
|
||
|
Existing technology
|
|
|
|
|
Customer relationships
|
|
|
|
|
Goodwill
|
|
|
|
|
Total
|
$
|
|
|
|
Tangible assets:
|
|
||
|
Property and equipment
|
$
|
|
|
|
Intangible assets:
|
|
||
|
Existing technology
|
|
|
|
|
Customer relationships
|
|
|
|
|
Production know-how
|
|
|
|
|
Backlog
|
|
|
|
|
Total
|
$
|
|
|
|
|
|
Aggregate Fair Value
|
|
Quoted Prices
in Active
Markets for
Identical
Assets
|
|
Significant
Other
Observable
Inputs
|
|
Aggregate Fair Value
|
|
Quoted Prices
in Active
Markets for
Identical
Assets
|
|
Significant
Other
Observable
Inputs
|
||||||||||||
|
|
|
April 4, 2020
|
|
September 28, 2019
|
||||||||||||||||||||
|
|
|
|
|
(Level 1)
|
|
(Level 2)
|
|
|
|
(Level 1)
|
|
(Level 2)
|
||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Money market fund deposits
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Certificates of deposit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
U.S. Treasury and agency obligations
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Prepaid and other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Foreign currency contracts
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Money market fund deposits — Deferred comp and supplemental plan
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Mutual funds — Deferred comp and supplemental plan
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign currency contracts
(2)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
(1)
|
Valuations are based upon quoted market prices in active markets involving similar assets. The market inputs used to value these instruments generally consist of market yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Pricing sources include industry standard data providers, security master files from large financial institutions, and other third party sources which are input into a distribution-curve-based algorithm to determine a daily market value. This creates a "consensus price" or a weighted average price for each security.
|
|
(2)
|
The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants usually are large commercial banks. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment. See Note 7, "Derivative Instruments and Hedging Activities."
|
|
(3)
|
|
|
|
April 4, 2020
|
||||||||||||||
|
|
Cost Basis
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
U.S. Treasury and agency obligations
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Corporate notes and obligations
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total short-term investments
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
September 28, 2019
|
||||||||||||||
|
|
Cost Basis
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
U.S. Treasury and agency obligations
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Total short-term investments
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
U.S. Notional Contract Value
|
|
U.S. Fair Value
|
||||||||||||
|
|
April 4, 2020
|
|
September 28, 2019
|
|
April 4, 2020
|
|
September 28, 2019
|
||||||||
|
Foreign currency hedge contracts
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Purchase
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Sell
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
|
OEM Laser Sources
|
|
Industrial Lasers & Systems
|
|
Total
|
||||||
|
Balance as of September 28, 2019
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Impairment charges
|
|
|
|
(
|
)
|
|
(
|
)
|
|||
|
Translation adjustments
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||
|
Balance as of April 4, 2020
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
April 4, 2020
|
|
September 28, 2019
|
||||||||||||||||||||
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
|
Existing technology
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Customer relationships
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
|
Trade name
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
|
Production know-how
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
|
Total
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Estimated Amortization
Expense
|
||
|
2020 (remainder)
|
$
|
|
|
|
2021
|
|
|
|
|
2022
|
|
|
|
|
2023
|
|
|
|
|
2024
|
|
|
|
|
2025
|
|
|
|
|
Thereafter
|
|
|
|
|
Total
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Purchased parts and assemblies
|
$
|
|
|
|
$
|
|
|
|
Work-in-process
|
|
|
|
|
|
||
|
Finished goods
|
|
|
|
|
|
||
|
Total inventories
|
$
|
|
|
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Prepaid and refundable income taxes
|
$
|
|
|
|
$
|
|
|
|
Other taxes receivable
|
|
|
|
|
|
||
|
Prepaid expenses and other assets
|
|
|
|
|
|
||
|
Total prepaid expenses and other assets
|
$
|
|
|
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Assets related to deferred compensation arrangements
|
$
|
|
|
|
$
|
|
|
|
Deferred tax assets
|
|
|
|
|
|
||
|
Right of use assets, net - operating leases (See Note 11)
|
|
|
|
|
|
||
|
Right of use assets, net - finance leases (See Note 11)
|
|
|
|
|
|
||
|
Other assets
(1)
|
|
|
|
|
|
||
|
Total other assets
|
$
|
|
|
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Accrued payroll and benefits
|
$
|
|
|
|
$
|
|
|
|
Operating lease liability, current (See Note 11)
|
|
|
|
|
|
||
|
Finance lease liability, current (See Note 11)
|
|
|
|
|
|
||
|
Deferred revenue
|
|
|
|
|
|
||
|
Warranty reserve
|
|
|
|
|
|
||
|
Accrued expenses and other
|
|
|
|
|
|
||
|
Customer deposits
|
|
|
|
|
|
||
|
Total other current liabilities
|
$
|
|
|
|
$
|
|
|
|
|
Six Months Ended
|
||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
||||
|
Beginning balance
|
$
|
|
|
|
$
|
|
|
|
Additions related to current period sales
|
|
|
|
|
|
||
|
Warranty costs incurred in the current period
|
(
|
)
|
|
(
|
)
|
||
|
Accruals resulting from acquisitions
|
|
|
|
|
|
||
|
Adjustments to accruals related to foreign exchange and other
|
(
|
)
|
|
(
|
)
|
||
|
Ending balance
|
$
|
|
|
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Long-term taxes payable
|
$
|
|
|
|
$
|
|
|
|
Operating lease liability, long-term (See Note 11)
|
|
|
|
|
|
||
|
Finance lease liability, long-term (See Note 11)
|
|
|
|
|
|
||
|
Deferred compensation
|
|
|
|
|
|
||
|
Defined benefit plan liabilities
|
|
|
|
|
|
||
|
Deferred tax liabilities
|
|
|
|
|
|
||
|
Deferred revenue
|
|
|
|
|
|
||
|
Asset retirement obligations liability
|
|
|
|
|
|
||
|
Other long-term liabilities
|
|
|
|
|
|
||
|
Total other long-term liabilities
|
$
|
|
|
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Current portion of Euro Term Loan
(1)
|
$
|
|
|
|
$
|
|
|
|
1.3% Term loan due 2024
|
|
|
|
|
|
||
|
1.0% State of Connecticut term loan due 2023
|
|
|
|
|
|
||
|
Capital lease obligations
|
|
|
|
|
|
||
|
Line of credit borrowings
|
|
|
|
|
|
||
|
Total short-term borrowings and current portion of long-term obligations
|
$
|
|
|
|
$
|
|
|
|
|
April 4,
2020 |
|
September 28,
2019 |
||||
|
Euro Term Loan due 2024
(1)
|
$
|
|
|
|
$
|
|
|
|
1.3% Term loan due 2024
|
|
|
|
|
|
||
|
1.0% State of Connecticut term loan due 2023
|
|
|
|
|
|
||
|
Capital lease obligations
|
|
|
|
|
|
||
|
Total long-term obligations
|
$
|
|
|
|
$
|
|
|
|
|
Amount
|
||
|
2020 (remainder)
|
$
|
|
|
|
2021
|
|
|
|
|
2022
|
|
|
|
|
2023
|
|
|
|
|
2024
|
|
|
|
|
Total
|
$
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||
|
|
April 4, 2020
|
|
April 4, 2020
|
||||
|
Operating lease cost
|
$
|
|
|
|
$
|
|
|
|
Variable lease cost
|
|
|
|
|
|
||
|
Short-term lease cost
|
|
|
|
|
|
||
|
Sublease income
|
(
|
)
|
|
(
|
)
|
||
|
Total lease cost
|
$
|
|
|
|
$
|
|
|
|
|
April 4, 2020
|
|
|
Weighted average remaining lease term
|
|
|
|
Weighted average discount rate
|
|
%
|
|
|
Six Months Ended
|
||
|
|
April 4, 2020
|
||
|
Operating cash outflows from operating leases
|
$
|
|
|
|
ROU assets obtained in exchange for new operating lease liabilities
|
|
|
|
|
|
Operating Leases
|
||
|
2020 (remainder)
|
$
|
|
|
|
2021
|
|
|
|
|
2022
|
|
|
|
|
2023
|
|
|
|
|
2024
|
|
|
|
|
2025 and thereafter
|
|
|
|
|
Total minimum lease payments
|
|
|
|
|
Amounts representing interest
|
(
|
)
|
|
|
Present value of total lease liabilities
|
$
|
|
|
|
|
Operating Leases
|
||
|
2020
|
$
|
|
|
|
2021
|
|
|
|
|
2022
|
|
|
|
|
2023
|
|
|
|
|
2024
|
|
|
|
|
2025 and thereafter
|
|
|
|
|
Total minimum lease payments
|
$
|
|
|
|
|
|
Employee Stock Purchase Plan
|
|
||||||||||||||
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
||||||||||||
|
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
|
||||||||
|
Expected life in years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Volatility
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
|
||||
|
Risk-free interest rate
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
|
||||
|
Expected dividend yield
|
|
|
%
|
|
|
%
|
|
|
%
|
|
|
%
|
|
||||
|
Weighted average fair value per share
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
Six Months Ended
|
||||||
|
|
|
April 4,
2020 |
|
March 30,
2019 |
||||
|
Risk-free interest rate
|
|
|
%
|
|
|
%
|
||
|
Volatility
|
|
|
%
|
|
|
%
|
||
|
Weighted average fair value per share
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
||||||||||||
|
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
|
||||||||
|
Cost of sales
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Research and development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Selling, general and administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Income tax benefit
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
||||
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Time-based Restricted Stock Units
|
|
Performance-based Restricted Stock Units
|
||||||||||
|
|
Number of
Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Number of
Shares
|
|
Weighted
Average Grant Date Fair Value |
||||||
|
Nonvested stock at September 28, 2019
|
|
|
|
$
|
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Vested
(1)
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||
|
Forfeited
|
(
|
)
|
|
|
|
|
|
|
|
|
|
||
|
Nonvested stock at April 4, 2020
|
|
|
|
$
|
|
|
|
|
|
|
$
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||||||
|
Weighted average shares outstanding—basic
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Dilutive effect of employee stock awards
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Weighted average shares outstanding—diluted
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||||||
|
Foreign exchange loss
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Gain (loss) on deferred compensation investments, net
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
||||
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Other—net
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
|
Six Months Ended
|
||
|
|
April 4,
2020 |
||
|
Balance as of the beginning of the year
|
$
|
|
|
|
Increases related to acquisitions
|
|
|
|
|
Tax positions related to current year:
|
|
||
|
Additions
|
|
|
|
|
Reductions
|
|
|
|
|
Tax positions related to prior year:
|
|
||
|
Additions
|
|
|
|
|
Reductions
|
|
|
|
|
Settlements
|
—
|
|
|
|
Lapses in statutes of limitations
|
(
|
)
|
|
|
Decrease in unrecognized tax benefits based on tax audit results
|
(
|
)
|
|
|
Foreign currency revaluation adjustment
|
(
|
)
|
|
|
Balance as of end of period
|
$
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||||||
|
Net sales:
|
|
|
|
|
|
|
|
||||||||
|
OEM Laser Sources
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Industrial Lasers & Systems
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Income (loss) from operations:
|
|
|
|
|
|
|
|
||||||||
|
OEM Laser Sources
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Industrial Lasers & Systems
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Corporate and other
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Total income (loss) from operations
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
Total other expense, net
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Income (loss) before income taxes
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
||||||||||||
|
SALES
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
|
||||||||
|
United States
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Foreign countries:
|
|
|
|
|
|
|
|
|
||||||||
|
South Korea
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
China
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Japan
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Asia-Pacific, other
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Germany
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Europe, other
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Rest of World
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total foreign countries sales
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Severance Related
|
|
Asset Write-Offs
|
|
Other
|
|
Total
|
||||||||
|
Balances, September 28, 2019
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Provision
|
|
|
|
|
|
|
|
|
|
||||||
|
Payments and other
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Balances, December 28, 2019
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Provision
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Payments and other
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Balances, April 4, 2020
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Severance Related
|
|
Asset Write-Offs
|
|
Other
|
|
Total
|
||||||||
|
Balances, September 29, 2018
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Provision
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Payments and other
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Balances, December 29, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Provision
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Payments and other
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Balances, March 30, 2019
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
•
|
Leverage our technology portfolio and application engineering to lead the proliferation of photonics into broader markets
—We will continue to identify opportunities in which our technology portfolio and application engineering can be used to offer innovative solutions and gain access to new markets. We plan to utilize our expertise to increase our market share in mid to high power material processing applications.
|
|
•
|
Streamline our manufacturing structure and improve our cost structure
—We will focus on optimizing the mix of products that we manufacture internally and externally. We will utilize vertical integration where our internal manufacturing process is considered proprietary and seek to leverage external sources when the capabilities and cost structures are well developed and on a path towards commoditization.
|
|
•
|
Focus on long-term improvement of adjusted EBITDA, in dollars and as a percentage of net sales
—We define adjusted EBITDA as operating income adjusted for depreciation, amortization, stock compensation expense, major restructuring costs and certain other non-operating income and expense items, such as costs related to our acquisitions. Key initiatives to reach our goals for EBITDA improvements include utilization of our Asian manufacturing locations, optimizing our supply chain and continued leveraging of our infrastructure.
|
|
•
|
Optimize our leadership position in existing markets
—There are a number of markets where we have historically been at the forefront of technological development and product deployment and from which we have derived a substantial portion of our revenues. We plan to optimize our financial returns from these markets.
|
|
•
|
Maintain and develop additional strong collaborative customer and industry relationships
—We believe that the Coherent brand name and reputation for product quality, technical performance and customer satisfaction will help us to further develop our loyal customer base. We plan to maintain our current customer relationships and develop new ones with customers who are industry leaders and work together with these customers to design and develop innovative product systems and solutions as they develop new technologies.
|
|
•
|
Develop and acquire new technologies and market share
—We will continue to enhance our market position through our existing technologies and develop new technologies through our internal research and development efforts, as well as through the acquisition of additional complementary technologies, intellectual property, manufacturing processes and product offerings.
|
|
|
Three Months Ended
|
|
|
|
|
|||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
|
Change
|
|
% Change
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Net sales—OEM Laser Sources
|
$
|
173,722
|
|
|
$
|
231,597
|
|
|
$
|
(57,875
|
)
|
|
(25.0
|
)%
|
|
Net sales—Industrial Lasers & Systems
|
$
|
119,425
|
|
|
$
|
141,263
|
|
|
$
|
(21,838
|
)
|
|
(15.5
|
)%
|
|
Gross profit as a percentage of net sales—OEM Laser Sources
|
45.6
|
%
|
|
46.6
|
%
|
|
(1.0
|
)%
|
|
|
|
|||
|
Gross profit as a percentage of net sales—Industrial Lasers & Systems
|
13.5
|
%
|
|
17.0
|
%
|
|
(3.5
|
)%
|
|
|
||||
|
Research and development as a percentage of net sales
|
10.2
|
%
|
|
8.2
|
%
|
|
2.0
|
%
|
|
|
|
|||
|
Income (loss) before income taxes
|
$
|
(454,974
|
)
|
|
$
|
24,615
|
|
|
$
|
(479,589
|
)
|
|
(1,948.4
|
)%
|
|
Net cash provided by operating activities
|
$
|
45,731
|
|
|
$
|
75,012
|
|
|
$
|
(29,281
|
)
|
|
(39.0
|
)%
|
|
Days sales outstanding in receivables
|
62
|
|
|
76
|
|
|
(14
|
)
|
|
|
|
|||
|
Annualized second quarter inventory turns
|
1.7
|
|
|
2.0
|
|
|
(0.3
|
)
|
|
|
|
|||
|
Net income (loss) as a percentage of net sales
|
(142.9
|
)%
|
|
5.6
|
%
|
|
(148.5
|
)%
|
|
|
|
|||
|
Adjusted EBITDA as a percentage of net sales
|
11.9
|
%
|
|
18.2
|
%
|
|
(6.3
|
)%
|
|
|
|
|||
|
|
Six Months Ended
|
|
|
|
|
|||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
|
Change
|
|
% Change
|
|||||||
|
|
(Dollars in thousands)
|
|||||||||||||
|
Net sales—OEM Laser Sources
|
$
|
374,670
|
|
|
$
|
473,945
|
|
|
$
|
(99,275
|
)
|
|
(20.9
|
)%
|
|
Net sales—Industrial Lasers & Systems
|
$
|
239,248
|
|
|
$
|
282,061
|
|
|
$
|
(42,813
|
)
|
|
(15.2
|
)%
|
|
Gross profit as a percentage of net sales—OEM Laser Sources
|
46.3
|
%
|
|
48.7
|
%
|
|
(2.4
|
)%
|
|
|
||||
|
Gross profit as a percentage of net sales—Industrial Lasers & Systems
|
13.5
|
%
|
|
18.3
|
%
|
|
(4.8
|
)%
|
|
|
||||
|
Research and development as a percentage of net sales
|
9.5
|
%
|
|
7.9
|
%
|
|
1.6
|
%
|
|
|
||||
|
Income (loss) before income taxes
|
$
|
(447,418
|
)
|
|
$
|
68,275
|
|
|
$
|
(515,693
|
)
|
|
(755.3
|
)%
|
|
Net cash provided by operating activities
|
$
|
105,772
|
|
|
$
|
126,323
|
|
|
$
|
(20,551
|
)
|
|
(16.3
|
)%
|
|
Net income (loss) as a percentage of net sales
|
(67.3
|
)%
|
|
7.4
|
%
|
|
(74.7
|
)%
|
|
|
||||
|
Adjusted EBITDA as a percentage of net sales
|
13.1
|
%
|
|
20.7
|
%
|
|
(7.6
|
)%
|
|
|
||||
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||
|
Net income (loss) as a percentage of net sales
|
(142.9
|
)%
|
|
5.6
|
%
|
|
(67.3
|
)%
|
|
7.4
|
%
|
|
Income tax expense (benefit)
|
(12.3
|
)%
|
|
1.0
|
%
|
|
(5.6
|
)%
|
|
1.6
|
%
|
|
Interest and other income (expense), net
|
1.5
|
%
|
|
1.5
|
%
|
|
1.5
|
%
|
|
1.7
|
%
|
|
Depreciation and amortization
|
8.4
|
%
|
|
7.5
|
%
|
|
8.2
|
%
|
|
7.5
|
%
|
|
Restructuring charges
|
0.3
|
%
|
|
0.2
|
%
|
|
0.3
|
%
|
|
0.2
|
%
|
|
Purchase accounting step-up
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
0.1
|
%
|
|
Goodwill and other impairment charges
|
153.9
|
%
|
|
—
|
%
|
|
73.3
|
%
|
|
—
|
%
|
|
Stock-based compensation
|
3.0
|
%
|
|
2.4
|
%
|
|
2.7
|
%
|
|
2.2
|
%
|
|
Adjusted EBITDA as a percentage of net sales
|
11.9
|
%
|
|
18.2
|
%
|
|
13.1
|
%
|
|
20.7
|
%
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
|
April 4,
2020 |
|
March 30,
2019 |
||||
|
Net sales
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of sales
|
67.9
|
%
|
|
64.9
|
%
|
|
66.9
|
%
|
|
63.0
|
%
|
|
Gross profit
|
32.1
|
%
|
|
35.1
|
%
|
|
33.1
|
%
|
|
37.0
|
%
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||
|
Research and development
|
10.2
|
%
|
|
8.2
|
%
|
|
9.5
|
%
|
|
7.9
|
%
|
|
Selling, general and administrative
|
20.9
|
%
|
|
18.7
|
%
|
|
21.2
|
%
|
|
17.7
|
%
|
|
Goodwill and other impairment charges
|
153.9
|
%
|
|
—
|
%
|
|
73.5
|
%
|
|
—
|
%
|
|
Amortization of intangible assets
|
0.4
|
%
|
|
0.5
|
%
|
|
0.4
|
%
|
|
0.6
|
%
|
|
Total operating expenses
|
185.4
|
%
|
|
27.4
|
%
|
|
104.6
|
%
|
|
26.2
|
%
|
|
Income (loss) from operations
|
(153.3
|
)%
|
|
7.7
|
%
|
|
(71.5
|
)%
|
|
10.8
|
%
|
|
Other expense, net
|
(1.9
|
)%
|
|
(1.1
|
)%
|
|
(1.4
|
)%
|
|
(1.8
|
)%
|
|
Income (loss) before income taxes
|
(155.2
|
)%
|
|
6.6
|
%
|
|
(72.9
|
)%
|
|
9.0
|
%
|
|
Provision for (benefit from) income taxes
|
(12.3
|
)%
|
|
1.0
|
%
|
|
(5.6
|
)%
|
|
1.6
|
%
|
|
Net income (loss)
|
(142.9
|
)%
|
|
5.6
|
%
|
|
(67.3
|
)%
|
|
7.4
|
%
|
|
|
Three Months Ended
|
||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||
|
|
Amount
|
|
Percentage
of total
net sales
|
|
Amount
|
|
Percentage
of total
net sales
|
||||||
|
Consolidated:
|
|
|
|
|
|
|
|
||||||
|
Microelectronics
|
$
|
121,767
|
|
|
41.5
|
%
|
|
$
|
169,265
|
|
|
45.4
|
%
|
|
Materials processing
|
86,307
|
|
|
29.5
|
%
|
|
104,922
|
|
|
28.1
|
%
|
||
|
OEM components and instrumentation
|
63,563
|
|
|
21.7
|
%
|
|
67,202
|
|
|
18.0
|
%
|
||
|
Scientific and government programs
|
21,510
|
|
|
7.3
|
%
|
|
31,471
|
|
|
8.5
|
%
|
||
|
Total
|
$
|
293,147
|
|
|
100.0
|
%
|
|
$
|
372,860
|
|
|
100.0
|
%
|
|
|
Six Months Ended
|
||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||
|
|
Amount
|
|
Percentage
of total
net sales
|
|
Amount
|
|
Percentage
of total
net sales
|
||||||
|
Consolidated:
|
|
|
|
|
|
|
|
||||||
|
Microelectronics
|
$
|
252,313
|
|
|
41.1
|
%
|
|
$
|
347,674
|
|
|
46.0
|
%
|
|
Materials processing
|
174,679
|
|
|
28.4
|
%
|
|
209,565
|
|
|
27.7
|
%
|
||
|
OEM components and instrumentation
|
132,914
|
|
|
21.7
|
%
|
|
133,555
|
|
|
17.7
|
%
|
||
|
Scientific and government programs
|
54,012
|
|
|
8.8
|
%
|
|
65,212
|
|
|
8.6
|
%
|
||
|
Total
|
$
|
613,918
|
|
|
100.0
|
%
|
|
$
|
756,006
|
|
|
100.0
|
%
|
|
|
Three Months Ended
|
||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||
|
|
Amount
|
|
Percentage
of total
net sales
|
|
Amount
|
|
Percentage
of total
net sales
|
||||||
|
Consolidated:
|
|
|
|
|
|
|
|
||||||
|
OEM Laser Sources (OLS)
|
$
|
173,722
|
|
|
59.3
|
%
|
|
$
|
231,597
|
|
|
62.1
|
%
|
|
Industrial Lasers & Systems (ILS)
|
119,425
|
|
|
40.7
|
%
|
|
141,263
|
|
|
37.9
|
%
|
||
|
Total
|
$
|
293,147
|
|
|
100.0
|
%
|
|
$
|
372,860
|
|
|
100.0
|
%
|
|
|
Six Months Ended
|
||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||
|
|
Amount
|
|
Percentage
of total
net sales
|
|
Amount
|
|
Percentage
of total
net sales
|
||||||
|
Consolidated:
|
|
|
|
|
|
|
|
||||||
|
OEM Laser Sources (OLS)
|
$
|
374,670
|
|
|
61.0
|
%
|
|
$
|
473,945
|
|
|
62.7
|
%
|
|
Industrial Lasers & Systems (ILS)
|
239,248
|
|
|
39.0
|
%
|
|
282,061
|
|
|
37.3
|
%
|
||
|
Total
|
$
|
613,918
|
|
|
100.0
|
%
|
|
$
|
756,006
|
|
|
100.0
|
%
|
|
|
Three Months Ended
|
||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||
|
|
Amount
|
|
Percentage of
total net sales
|
|
Amount
|
|
Percentage of
total net sales
|
||||||
|
|
(Dollars in thousands)
|
||||||||||||
|
Research and development
|
$
|
29,794
|
|
|
10.2
|
%
|
|
$
|
30,461
|
|
|
8.2
|
%
|
|
Selling, general and administrative
|
61,307
|
|
|
20.9
|
%
|
|
69,463
|
|
|
18.7
|
%
|
||
|
Goodwill and other impairment charges
|
451,025
|
|
|
153.9
|
%
|
|
—
|
|
|
—
|
%
|
||
|
Amortization of intangible assets
|
1,296
|
|
|
0.4
|
%
|
|
1,926
|
|
|
0.5
|
%
|
||
|
Total operating expenses
|
$
|
543,422
|
|
|
185.4
|
%
|
|
$
|
101,850
|
|
|
27.4
|
%
|
|
|
Six Months Ended
|
||||||||||||
|
|
April 4, 2020
|
|
March 30, 2019
|
||||||||||
|
|
Amount
|
|
Percentage of
total net sales
|
|
Amount
|
|
Percentage of
total net sales
|
||||||
|
|
(Dollars in thousands)
|
||||||||||||
|
Research and development
|
$
|
58,474
|
|
|
9.5
|
%
|
|
$
|
59,403
|
|
|
7.9
|
%
|
|
Selling, general and administrative
|
129,858
|
|
|
21.2
|
%
|
|
134,020
|
|
|
17.7
|
%
|
||
|
Goodwill and other impairment charges
|
451,025
|
|
|
73.5
|
%
|
|
—
|
|
|
—
|
%
|
||
|
Amortization of intangible assets
|
2,728
|
|
|
0.4
|
%
|
|
4,966
|
|
|
0.6
|
%
|
||
|
Total operating expenses
|
$
|
642,085
|
|
|
104.6
|
%
|
|
$
|
198,389
|
|
|
26.2
|
%
|
|
|
Three Months Ended
|
||||||
|
|
April 4,
2020 |
|
March 30,
2019 |
||||
|
|
(in thousands)
|
||||||
|
Net cash provided by operating activities
|
$
|
105,772
|
|
|
$
|
126,323
|
|
|
Acquisition of businesses, net of cash acquired
|
—
|
|
|
(18,881
|
)
|
||
|
Investment in 3D-Micromac AG
|
—
|
|
|
(3,423
|
)
|
||
|
Issuance of shares under employee stock plans
|
6,821
|
|
|
5,704
|
|
||
|
Net settlement of restricted common stock
|
(13,299
|
)
|
|
(15,141
|
)
|
||
|
Repurchases of common stock
|
—
|
|
|
(51,406
|
)
|
||
|
Borrowings (repayments), net
|
(4,757
|
)
|
|
36,387
|
|
||
|
Purchases of property and equipment
|
(35,399
|
)
|
|
(41,525
|
)
|
||
|
|
April 4, 2020
|
|
September 28, 2019
|
||||
|
|
(in thousands)
|
||||||
|
Cash and cash equivalents
|
$
|
369,251
|
|
|
$
|
305,833
|
|
|
Short-term investments
|
116
|
|
|
120
|
|
||
|
Working capital
|
857,879
|
|
|
854,507
|
|
||
|
•
|
general economic uncertainties in the macroeconomic and local economies facing us, our customers and the markets we serve, particularly as the novel coronavirus ("COVID-19") outbreak continues to adversely affect the global economy;
|
|
•
|
impact of government economic policies on macroeconomic conditions, such as recently instituted, proposed or threatened changes in trade policies by the U.S. and any corresponding retaliatory actions by affected countries, in particular with respect to China, and trade restrictions the Japanese government has recently instituted affecting the export to South Korea of certain products and materials used in the manufacture of flat panel displays and in the semiconductor industry;
|
|
•
|
fluctuations in demand for our products or downturns in the industries that we serve, particularly the continued build-out of “phase 2” of the capacity for the manufacture of OLED and the increased use of the installed base of our products in such manufacturing;
|
|
•
|
the ability of our suppliers, both internal and external, to produce and deliver components and parts, including sole or limited source components, in a timely manner, in the quantity, quality and prices desired;
|
|
•
|
the timing of receipt of bookings and the timing of and our ability to ultimately convert bookings to net sales;
|
|
•
|
the concentration of a significant amount of our backlog, and resultant net sales, with a few customers in the Microelectronics market;
|
|
•
|
rescheduling of shipments or cancellation of orders by our customers;
|
|
•
|
fluctuations in our product mix;
|
|
•
|
the ability of our customers' other suppliers to provide sufficient material to support our customers' products;
|
|
•
|
currency fluctuations and stability, in particular the Euro, the Japanese Yen, the South Korean Won, the Chinese RMB and the U.S. Dollar as compared to other currencies;
|
|
•
|
commodity pricing;
|
|
•
|
interpretation and impact of the U.S. Tax Cuts and Jobs Act (the "Tax Act") and the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act");
|
|
•
|
introductions of new products and product enhancements by our competitors, entry of new competitors into our markets, pricing pressures and other competitive factors;
|
|
•
|
the increasing focus by companies in China to vertically integrate and consolidate their supply chains fully with products manufactured in China;
|
|
•
|
our ability to develop, introduce, manufacture and ship new and enhanced products in a timely manner without defects;
|
|
•
|
our ability to manage our manufacturing capacity across our diverse product lines and that of our suppliers, including our ability to successfully expand our manufacturing capacity in various locations around the world;
|
|
•
|
our ability to successfully and fully integrate acquisitions, such as the historical Rofin businesses, into our operations and management;
|
|
•
|
our ability to successfully internally transfer the manufacturing of products and related operations as part of our integration and internal reorganization efforts and to realize anticipated benefits (including savings) therefrom, such as with our recently announced plan to co-locate the manufacturing and engineering of our High Power Fiber Lasers ("HPFL") products at our Hamburg, Germany, facility to our Tampere, Finland, location and exit a portion of our HPFL business;
|
|
•
|
our reliance on contract manufacturing;
|
|
•
|
our reliance in part upon the ability of our OEM customers to develop and sell systems that incorporate our laser products;
|
|
•
|
our customers' ability to manage their susceptibility to adverse economic conditions;
|
|
•
|
the rate of market acceptance of our new products;
|
|
•
|
the ability of our customers to pay for our products;
|
|
•
|
expenses associated with acquisition-related activities, including the costs of acquiring businesses or technologies;
|
|
•
|
seasonal sales trends, including with respect to Rofin's historical business, which has traditionally experienced a reduction in sales during the first half of its fiscal year as compared to the second half of its fiscal year;
|
|
•
|
jurisdictional capital and currency controls negatively impacting our ability to move funds from or to an applicable jurisdiction;
|
|
•
|
access to applicable credit markets by us, our customers and their end customers;
|
|
•
|
the impact of rising Chinese consumer debt and eroding consumer confidence and spending in China;
|
|
•
|
delays or reductions in customer purchases of our products in anticipation of the introduction of new and enhanced products by us or our competitors;
|
|
•
|
our ability to control expenses;
|
|
•
|
the level of capital spending of our customers;
|
|
•
|
potential excess and/or obsolescence of our inventory;
|
|
•
|
costs and timing of adhering to current and developing governmental regulations and reviews relating to our products and business, including import and export regulations in multiple jurisdictions;
|
|
•
|
impairment of goodwill, intangible assets and other long-lived assets;
|
|
•
|
our ability to meet our expectations and forecasts and those of public market analysts and investors;
|
|
•
|
the availability of research funding by governments with regard to our customers in the scientific business, such as universities;
|
|
•
|
continued government spending on defense-related and scientific research projects where we are a vendor directly or as a subcontractor;
|
|
•
|
maintenance of supply relating to products sold to the government on terms which we would prefer not to accept;
|
|
•
|
changes in policy, interpretations, or challenges to the allowability of costs incurred under government cost accounting standards;
|
|
•
|
our ability and the ability of our contractual counterparts to comply with the terms of our contracts;
|
|
•
|
damage to our reputation as a result of coverage in social media, Internet blogs or other media outlets;
|
|
•
|
managing our and other parties' compliance with contracts in multiple languages and jurisdictions;
|
|
•
|
managing our internal and third party sales representatives and distributors, including compliance with all applicable laws;
|
|
•
|
costs, expenses and damages arising from litigation;
|
|
•
|
costs associated with designing around or payment of licensing fees associated with issued patents in our fields of business;
|
|
•
|
individual employees intentionally or negligently failing to comply with our internal controls;
|
|
•
|
government support of alternative energy industries, such as solar;
|
|
•
|
negative impacts related to the "Brexit" vote by the United Kingdom, including uncertainties regarding the effects of the Brexit process and the timing and terms of applicable trade treaties between the United Kingdom and other countries, particularly with regard to any potential negative effects on our sales from our Glasgow, Scotland facility to other jurisdictions and purchases of supplies from outside the United Kingdom by such facility;
|
|
•
|
negative impacts related to the recent independence movement in Catalonia, Spain, particularly with regard to holding and operating some of our foreign entities in an efficient manner from a tax, business and legal perspective;
|
|
•
|
negative impacts related to government instability in any jurisdiction in which we operate, such as the recent difficulties in forming a governing coalition in Germany;
|
|
•
|
the future impact of legislation, rulemaking, and changes in accounting, tax, defense procurement and export policies; and
|
|
•
|
distraction of management related to acquisition, integration or divestment activities.
|
|
•
|
the inability to successfully combine our business with Rofin in a manner that permits the combined company to achieve the full synergies and other benefits anticipated to result from the merger;
|
|
•
|
complexities associated with managing the combined businesses, including difficulty addressing possible differences in corporate cultures and management philosophies and the challenge of integrating products, services, complex and different information technology systems (including different Enterprise Management Systems), control and compliance processes, technology, networks and other assets of each of the companies in a cohesive manner;
|
|
•
|
diversion of the attention of our management;
|
|
•
|
the disruption of, or the loss of momentum in, our business; and
|
|
•
|
inconsistencies in standards, controls, procedures or policies.
|
|
•
|
loss of customers or orders;
|
|
•
|
increased costs of product returns and warranty expenses;
|
|
•
|
damage to our brand reputation;
|
|
•
|
failure to attract new customers or achieve market acceptance;
|
|
•
|
diversion of development, engineering and manufacturing resources; and
|
|
•
|
legal actions by our customers and/or their end users.
|
|
•
|
compliance with applicable import/export regulations, tariffs and trade barriers, including recently instituted or proposed changes in trade policies by the U.S. and any corresponding retaliatory actions by affected countries, in particular with respect to China;
|
|
•
|
longer accounts receivable collection periods;
|
|
•
|
the impact of recessions and other economic conditions in economies outside the United States, including, for example, recent dips in the manufacturing Purchasing Managers’ Index ("PMI") as well as the Institute of Supply Management ("ISM") data in the Eurozone, in particular in Germany;
|
|
•
|
unexpected changes in regulatory requirements;
|
|
•
|
certification requirements;
|
|
•
|
environmental regulations;
|
|
•
|
reduced protection for intellectual property rights in some countries;
|
|
•
|
potentially adverse tax consequences;
|
|
•
|
political and economic instability, such as the current situation between the governments of Japan and South Korea, which has led to the imposition of trade restrictions by the Japanese government affecting the export to South Korea of certain products and materials used in the manufacture of flat panel displays and in the semiconductor industry;
|
|
•
|
compliance with applicable United States and foreign anti-corruption laws;
|
|
•
|
less than favorable contract terms;
|
|
•
|
reduced ability to enforce contractual obligations;
|
|
•
|
cultural and management differences;
|
|
•
|
reliance in some jurisdictions on third party sales channel partners;
|
|
•
|
preference for locally produced products; and
|
|
•
|
shipping and other logistics complications.
|
|
•
|
stop manufacturing, selling or using our products that use the infringed intellectual property;
|
|
•
|
obtain from the owner of the infringed intellectual property right a license to sell or use the relevant technology, although such license may not be available on reasonable terms, or at all; or
|
|
•
|
redesign the products that use the technology.
|
|
•
|
issue stock that would dilute our current stockholders' percentage ownership;
|
|
•
|
pay cash that would decrease our working capital;
|
|
•
|
incur debt;
|
|
•
|
assume liabilities; or
|
|
•
|
incur expenses related to impairment of goodwill and other long-lived assets, as we incurred in the quarter ending April 4, 2020 totaling
$451.0 million
.
|
|
•
|
problems combining the acquired operations, systems, technologies or products;
|
|
•
|
an inability to realize expected operating efficiencies or product integration benefits;
|
|
•
|
difficulties in coordinating and integrating geographically separated personnel, organizations, systems and facilities;
|
|
•
|
difficulties integrating business cultures;
|
|
•
|
unanticipated costs or liabilities, including the costs associated with improving the internal controls of the acquired company;
|
|
•
|
diversion of management's attention from our core businesses;
|
|
•
|
adverse effects on existing business relationships with suppliers and customers;
|
|
•
|
potential loss of key employees, particularly those of the purchased organizations;
|
|
•
|
incurring unforeseen obligations or liabilities in connection with acquisitions; and
|
|
•
|
the failure to complete acquisitions even after signing definitive agreements which, among other things, would result in the expensing of potentially significant professional fees and other charges in the period in which the acquisition or negotiations are terminated.
|
|
•
|
maintaining and enhancing our relationships with our customers;
|
|
•
|
the education of potential end-user customers about the benefits of lasers and laser systems; and
|
|
•
|
our ability to accurately predict and develop our products to meet industry standards.
|
|
•
|
interpretation and impact of the recently enacted and aforementioned U.S. tax laws, the Tax Act and the CARES Act;
|
|
•
|
changes in our current and future global structure based on the Rofin acquisition and restructuring that involved significant movement of U.S. and foreign entities and our ability to maintain favorable tax treatment as a result of various Rofin restructuring efforts and business activities;
|
|
•
|
the outcome of discussions with various tax authorities regarding intercompany transfer pricing arrangements;
|
|
•
|
changes that involve other acquisitions, restructuring or an increased investment in technology outside of the United States to better align asset ownership and business functions with revenues and profits;
|
|
•
|
changes in the composition of earnings in countries or states with differing tax rates;
|
|
•
|
the resolution of issues arising from tax audits with various tax authorities, and in particular, the outcome of the German tax audits for fiscal 2010-2016 and the appeals of the South Korean fiscal 2014-2017 tax audits through the competent authority process between South Korea, Germany and the United States;
|
|
•
|
adjustments to estimated taxes upon finalization of various tax returns;
|
|
•
|
increases in expenses not deductible for tax purposes, including impairments of goodwill in connection with acquisitions;
|
|
•
|
our ability to meet the eligibility requirements for tax holidays of limited time tax-advantage status;
|
|
•
|
changes in available tax credits;
|
|
•
|
changes in share-based compensation;
|
|
•
|
changes in other tax laws or the interpretation of such tax laws, including the Base Erosion Profit Shifting action plan implemented by the Organization for Economic Co-operation and Development;
|
|
•
|
changes in generally accepted accounting principles; and
|
|
•
|
significant fluctuations in business activities due to the COVID-19 pandemic.
|
|
•
|
the ability of our Board of Directors to alter our bylaws without stockholder approval;
|
|
•
|
limiting the ability of stockholders to call special meetings; and
|
|
•
|
establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted on by stockholders at stockholder meetings.
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
10.1
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
32.1*
|
|
|
|
|
|
|
|
32.2*
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
|
|
104
|
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
|
|
|
|
Coherent, Inc.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
Date:
|
May 28, 2020
|
/s/:
|
ANDREAS W. MATTES
|
|
|
|
|
Andreas W. Mattes
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
Date:
|
May 28, 2020
|
/s/:
|
KEVIN S. PALATNIK
|
|
|
|
|
Kevin S. Palatnik
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|